Literature DB >> 20854680

Fatigue in fibromyalgia: a conceptual model informed by patient interviews.

Louise Humphrey1, Rob Arbuckle, Philip Mease, David A Williams, Bente Danneskiold Samsoe, Claire Gilbert.   

Abstract

BACKGROUND: Fatigue is increasingly recognized as an important symptom in fibromyalgia (FM). Unknown however is how fatigue is experienced by individuals in the context of FM. We conducted qualitative research in order to better understand aspects of fatigue that might be unique to FM as well as the impact it has on patients' lives. The data obtained informed the development of a conceptual model of fatigue in FM.
METHODS: Open-ended interviews were conducted with 40 individuals with FM (US [n = 20], Germany [n = 10] and France [n = 10]). Transcripts were analyzed using qualitative methods based upon grounded theory to identify key themes and concepts.
RESULTS: Participants were mostly female (70%) with a mean age of 48.7 years (range: 25-79). Thirty-one individuals (i.e., 77.5%) spontaneously described experiencing tiredness/lack of energy/fatigue due to FM. Participants discussed FM fatigue as being more severe, constant/persistent and unpredictable than normal tiredness. The conceptual model depicts the key elements of fatigue in FM from a patient perspective. This includes: an overwhelming feeling of tiredness (n = 17, 42.5%), not relieved by resting/sleeping (n = 15, 37.5%), not proportional to effort exerted (n = 25, 62.5%), associated with a feeling of weakness/heaviness (n = 20, 50%), interferes with motivation (n = 22, 55%), interferes with desired activities (n = 27, 67.5%), prolongs tasks (n = 15, 37.5%), and makes it difficult to concentrate (n = 21, 52.5%), think clearly (n = 12, 30%) or remember things (n = 9, 22.5%).
CONCLUSION: The majority of individuals with FM who participated in this study experience fatigue and describe it as more severe than normal tiredness.

Entities:  

Mesh:

Year:  2010        PMID: 20854680      PMCID: PMC2946273          DOI: 10.1186/1471-2474-11-216

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  33 in total

1.  A phenomenological study of fibromyalgia. Patient perspectives.

Authors:  O Hellström; J Bullington; G Karlsson; P Lindqvist; B Mattsson
Journal:  Scand J Prim Health Care       Date:  1999-03       Impact factor: 2.581

2.  Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study.

Authors:  F Salaffi; R De Angelis; W Grassi
Journal:  Clin Exp Rheumatol       Date:  2005 Nov-Dec       Impact factor: 4.473

3.  The lived experience of fibromyalgia in African American women.

Authors:  Karen Moore Schaefer
Journal:  Holist Nurs Pract       Date:  2005 Jan-Feb       Impact factor: 1.000

4.  Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.

Authors:  Leslie J Crofford; Michael C Rowbotham; Philip J Mease; I Jon Russell; Robert H Dworkin; Ann E Corbin; James P Young; Linda K LaMoreaux; Susan A Martin; Uma Sharma
Journal:  Arthritis Rheum       Date:  2005-04

5.  Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Authors:  R C Lawrence; C G Helmick; F C Arnett; R A Deyo; D T Felson; E H Giannini; S P Heyse; R Hirsch; M C Hochberg; G G Hunder; M H Liang; S R Pillemer; V D Steen; F Wolfe
Journal:  Arthritis Rheum       Date:  1998-05

6.  Individuals' descriptions of living with fibromyalgia.

Authors:  Margaret Mui Cunningham; Carol Jillings
Journal:  Clin Nurs Res       Date:  2006-11       Impact factor: 2.075

7.  Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research.

Authors:  C Pope; N Mays
Journal:  BMJ       Date:  1995-07-01

8.  The prevalence and meaning of fatigue in rheumatic disease.

Authors:  F Wolfe; D J Hawley; K Wilson
Journal:  J Rheumatol       Date:  1996-08       Impact factor: 4.666

9.  Fibromyalgia syndrome.

Authors:  Philip Mease; Lesley M Arnold; Robert Bennett; Annelies Boonen; Dan Buskila; Serena Carville; Amy Chappell; Ernest Choy; Daniel Clauw; Dina Dadabhoy; Michael Gendreau; Don Goldenberg; Geoffrey Littlejohn; Susan Martin; Philip Perera; I Jon Russell; Lee Simon; Michael Spaeth; David Williams; Leslie Crofford
Journal:  J Rheumatol       Date:  2007-06       Impact factor: 4.666

10.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

View more
  28 in total

Review 1.  Monotherapy or combination therapy for fibromyalgia treatment?

Authors:  Elena Pita Calandre; Fernando Rico-Villademoros; Carmen María Rodríguez-López
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

2.  The PROMIS fatigue item bank has good measurement properties in patients with fibromyalgia and severe fatigue.

Authors:  Kathleen J Yost; Niels G Waller; Minji K Lee; Ann Vincent
Journal:  Qual Life Res       Date:  2017-01-30       Impact factor: 4.147

3.  A comparison of impact of fatigue on cognitive, physical, and psychosocial status in patients with fibromyalgia and rheumatoid arthritis.

Authors:  Jülide Oncü; Fatma Başoğlu; Banu Kuran
Journal:  Rheumatol Int       Date:  2013-07-24       Impact factor: 2.631

4.  Gene expression profiles of fatigued fibromyalgia patients with different categories of pain and catastrophizing: a preliminary report.

Authors:  Nada Lukkahatai; Benjamin Majors; Swarnalatha Reddy; Brian Walitt; Leorey N Saligan
Journal:  Nurs Outlook       Date:  2013-05-16       Impact factor: 3.250

Review 5.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

6.  The PROMIS FatigueFM Profile: a self-report measure of fatigue for use in fibromyalgia.

Authors:  Anna L Kratz; Stephen Schilling; Jenna Goesling; David A Williams
Journal:  Qual Life Res       Date:  2016-01-28       Impact factor: 4.147

7.  Phenotypic Features of Central Sensitization.

Authors:  David A Williams
Journal:  J Appl Biobehav Res       Date:  2018-06-27

8.  Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective "real world" data analysis of fibromyalgia patients.

Authors:  Martin Offenbaecher; Niko Kohls; Thomas Ewert; Claudia Sigl; Robin Hieblinger; Loren L Toussaint; Fuschia Sirois; Jameson Hirsch; Miguel A Vallejo; Sybille Kramer; Javier Rivera; Gerold Stucki; Jörg Schelling; Andreas Winkelmann
Journal:  Rheumatol Int       Date:  2021-03-05       Impact factor: 2.631

9.  Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.

Authors:  Lesley M Arnold; Fujun Wang; Jonna Ahl; Paula J Gaynor; Madelaine M Wohlreich
Journal:  Arthritis Res Ther       Date:  2011-06-13       Impact factor: 5.156

10.  Contextualizing goal preferences in fear-avoidance models. Looking at fatigue as a disabling symptom in fibromyalgia patients.

Authors:  Cecilia Peñacoba; Irene López-Gómez; Maria Angeles Pastor-Mira; Sofía López-Roig; Carmen Ecija
Journal:  PLoS One       Date:  2021-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.